Casdin Partners Master Fund L.P. insider trades

Open-market stock purchases and sales by Casdin Partners Master Fund L.P., 10% Owner at Biolife Solutions Inc, from SEC Form 4 filings since Nov 19, 2019.

Track record: 23% of 64 scored buys are up 5% or more since purchase, averaging -9%.

Recent trades

DateStockTradeValue
May 21, 2026BLFS Biolife Solutions IncSold$15.4M
May 20, 2026BLFS Biolife Solutions IncSold$5.9M
May 19, 2026BLFS Biolife Solutions IncSold$6.8M
Dec 4, 2025LAB Standard Biotools IncBought$217K
Dec 3, 2025LAB Standard Biotools IncBought$108K
Dec 2, 2025LAB Standard Biotools IncBought$178K
Nov 25, 2025LAB Standard Biotools IncBought$9.8M
Nov 24, 2025LAB Standard Biotools IncBought$215K
Nov 20, 2025LAB Standard Biotools IncBought$586K
Nov 19, 2025LAB Standard Biotools IncBought$449K
Nov 18, 2025LAB Standard Biotools IncBought$339K
Nov 17, 2025LAB Standard Biotools IncBought$276K
Nov 14, 2025LAB Standard Biotools IncBought$310K
Nov 13, 2025LAB Standard Biotools IncBought$541K
Nov 12, 2025LAB Standard Biotools IncBought$446K
Nov 11, 2025LAB Standard Biotools IncBought$359K
Nov 10, 2025LAB Standard Biotools IncBought$322K
Nov 7, 2025LAB Standard Biotools IncBought$253K
Oct 15, 2025BLFS Biolife Solutions IncSold$21.4M

Companies traded

  • BLFS Biolife Solutions Inc: 14 buys, 7 sales, last May 21, 2026
  • LAB Standard Biotools Inc: 52 buys, last Dec 4, 2025
  • MXCT Maxcyte, Inc: 1 buy, 2 sales, last Oct 3, 2022
  • TNYA Tenaya Therapeutics, Inc: 1 buy, last Aug 3, 2021
  • ABSI Absci Corp: 1 buy, last Jul 26, 2021
  • VERV Verve Therapeutics, Inc: 1 buy, last Jun 21, 2021
  • DBTX Decibel Therapeutics, Inc: 1 buy, last Feb 17, 2021

Get free alerts when Casdin Partners Master Fund L.P. files a new trade →